Iranian Journal of Pediatrics

Published by: Kowsar

The Incidence of Upper Urinary Tract Deterioration among Iranian Neonates with Spinal Dysraphism

Manoochehr Ghorbanpoor 1 , * , Abdol-Mohammad Kajbafzadeh 2 , Farideh Nejat 3 and Siavash Rahimi 4
Authors Information
1 Department of Surgery, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Pediatric Urology Research Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Neurosurgery, Children’s Hospital Medical Center, Tehran University of Medical Sciences, Tehran, IR Iran
4 School of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Iranian Journal of Pediatrics: April 2018, 28 (2); e59680
  • Published Online: March 24, 2018
  • Article Type: Research Article
  • Received: August 7, 2017
  • Revised: January 28, 2018
  • Accepted: February 15, 2018
  • DOI: 10.5812/ijp.59680

To Cite: Ghorbanpoor M, Kajbafzadeh A, Nejat F, Rahimi S. The Incidence of Upper Urinary Tract Deterioration among Iranian Neonates with Spinal Dysraphism, Iran J Pediatr. 2018 ; 28(2):e59680. doi: 10.5812/ijp.59680.

Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Talebian A, Soltani B, Sehat M, Zahedi A, Noorian A, Talebian M. Incidence and Risk Factors of Neural Tube Defects in Kashan, Central Iran. Iran J Child Neurol. 2015;9(3):50-6. [PubMed: 26401153].
  • 2. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg. 2001;34(3):114-20. doi: 10.1159/000056005. [PubMed: 11359098].
  • 3. Adzick NS. Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention. Semin Fetal Neonatal Med. 2010;15(1):9-14. doi: 10.1016/j.siny.2009.05.002. [PubMed: 19540177].
  • 4. Adzick NS. Fetal surgery for myelomeningocele: trials and tribulations. Isabella Forshall Lecture. J Pediatr Surg. 2012;47(2):273-81. doi: 10.1016/j.jpedsurg.2011.11.021. [PubMed: 22325376].
  • 5. Liptak GS, Kennedy JA, Dosa NP. Youth with spina bifida and transitions: health and social participation in a nationally represented sample. J Pediatr. 2010;157(4):584-588. e1.
  • 6. Yi Y, Lindemann M, Colligs A, Snowball C. Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr. 2011;170(11):1391-400. doi: 10.1007/s00431-011-1492-8. [PubMed: 21594574].
  • 7. Veenboer PW, Bosch JL, van Asbeck FW, de Kort LM. Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One. 2012;7(10). e48399. doi: 10.1371/journal.pone.0048399. [PubMed: 23119003].
  • 8. Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol. 1997;157(6):2295-7. [PubMed: 9146656].
  • 9. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele. J Urol. 1999;162(3 Pt 2):1068-71. [PubMed: 10458433].
  • 10. Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154(4):1500-4. [PubMed: 7658577].
  • 11. Ghoniem GM, Roach MB, Lewis VH, Harmon EP. The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients. J Urol. 1990;144(6):1440-2. [PubMed: 2231938].
  • 12. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126(2):205-9. [PubMed: 7196460].
  • 13. Rodriguez-Ruiz M, Somoza I, Curros-Mata N. Study of kidney damage in paediatric patients with neurogenic bladder and its relationship with the pattern of bladder function and treatment received. Actas Urol Esp. 2016;40(1):37-42. doi: 10.1016/j.acuro.2015.06.002. [PubMed: 26183019].
  • 14. Obara K, Mizusawa T, Isahaya E, Suzuki K, Hara N, Takahashi K. Efficacy of Clean Intermittent Catheterization for Urinary Incontinence in Children with Neurogenic Bladder Dysfunction Secondary to Myelodysplasia. Low Urin Tract Symptoms. 2010;2(2):100-5. doi: 10.1111/j.1757-5672.2010.00070.x. [PubMed: 26676291].
  • 15. Geraniotis E, Koff SA, Enrile B. The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol. 1988;139(1):85-6. [PubMed: 3336111].
  • 16. Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child. 1992;146(7):840-3. [PubMed: 1496955].
  • 17. Bauer SB. The argument for early assessment and treatment of infants with spina bifida. Dialogues Pediatr Urol. 2000;23(11):2.
  • 18. McDonald CM, Scavone T. Initiation of clean intermittent catheterization in infants with myelodysplasia. Dialogues Pediatr Urol. 2000;23(11):4-5.
  • 19. Tarcan T, Sekerci CA, Akbal C, Tinay I, Tanidir Y, Sahan A. Is 40 cm H2 O detrusor leak point pressure cut-off reliable for upper urinary tract protection in children with myelodysplasia? Neurourol Urodyn. 2017;36(3):759-63. doi: 10.1002/nau.23017. [PubMed: 27080436].
  • 20. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol. 2003;169(1):305-8. doi: 10.1097/01.ju.0000040590.35948.bc. [PubMed: 12478177].
  • 21. Sager C, Burek C, Corbetta JP, Weller S, Ruiz J, Perea R. Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele. J Pediatr Urol. 2017;13(3):271 e1-5. doi: 10.1016/j.jpurol.2016.12.024. [PubMed: 28215830].
  • 22. Torre M, Guida E, Bisio G, Scarsi P, Piatelli G, Cama A. Risk factors for renal function impairment in a series of 502 patients born with spinal dysraphisms. J Pediatr Urol. 2011;7(1):39-43. doi: 10.1016/j.jpurol.2010.02.210. [PubMed: 20363192].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments